Streetbeat News

Products Services

MRNA

Moderna announced that two abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, will be presented at the 2023 ASCO Annual Meeting in Chicago.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:09 pm

MCAG

MRK

AUM Biosciences has dosed its first patient in a Phase 2 clinical trial for AUM001, a treatment for metastatic colorectal cancer. The trial is being conducted in collaboration with MSD, a tradename of Merck & Co., Inc. AUM Biosciences plans to merge with Mountain Crest Acquisition Corp. V (NASDAQ:MCAG) and trade on the Nasdaq under the ticker symbol AUMB.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 12:09 pm

CWBR

Morphogenesis and CohBar have announced the acceptance of an abstract for a poster presentation at the 2023 ASCO Meeting. The companies recently entered into a definitive merger agreement for an all-stock transaction to form TuHURA Biosciences, Inc., which will trade on Nasdaq. The transaction is expected to close in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:07 pm

JNJ

Janssen has submitted a New Drug Application (NDA) for a single tablet combination therapy of macitentan and tadalafil for the long-term treatment of pulmonary arterial hypertension in adult patients.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:05 pm

AMLX

Amylyx Pharmaceuticals has been informed that the CHMP is trending toward a negative opinion on the application for conditional marketing authorization for AMX0035, a treatment for ALS.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:05 pm

IMNN

IMUNON presented preclinical data for its PlaCCine therapeutic at the 2023 Viruses and Cells Gordon Research Conference, showcasing its potential in treating viral infections.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:02 pm

ACB

Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), and Ethypharm have been selected as exclusive suppliers of dried medical cannabis flower for the French medical marijuana trial, which has been extended until March 2024.

Portfolio Pulse from Vuk Zdinjak

May 30, 2023 | 11:56 am

SDC

SDC U.S. SmilePay SPV has been granted U.S. Patent #11663852 for its machine learning architecture for imaging protocol detector. This technology could potentially improve the efficiency and accuracy of dental imaging.

Portfolio Pulse from Charles Gross

May 30, 2023 | 11:43 am

AKBA

The FDA has denied Akebia Therapeutics' appeal for vadadustat but provided a path forward for resubmitting the new drug application (NDA) for treating anemia due to chronic kidney disease (CKD) in dialysis-dependent patients.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:32 am

GNPX

Genprex has received approval from the Safety Review Committee to advance to the Phase 2 expansion portion of the Acclaim-1 clinical trial of REQORSA in combination with Tagrisso for advanced non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:31 am